Literature DB >> 33270200

Target Profiling of an Anticancer Drug Curcumin by an In Situ Chemical Proteomics Approach.

Dan-Dan Liu1, Chang Zou2, Jianbin Zhang3, Peng Gao1, Yongping Zhu1, Yuqing Meng1, Nan Ma1, Ming Lv1, Chengchao Xu1,2, Qingsong Lin4, Jigang Wang5,6.   

Abstract

Interdisciplinary chemical proteomics approaches have been widely applied to the identification of specific targets of bioactive small molecules or drugs. In this chapter, we describe the application of a cell-permeable activity-based curcumin probe (Cur-P) with an alkyne moiety to detect and identify specific binding targets of curcumin in HCT116 colon cancer cells. Through click chemistry, a fluorescent tag or a biotin tag is attached to the probe-modified curcumin targets for visualization or affinity purification followed by mass spectrometric identification. A quantitative proteomics approach of isobaric tags for relative and absolute quantification (iTRAQ)™ is applied to distinguish specific curcumin targets from nonspecific binding proteins.

Entities:  

Keywords:  Activity-Based probe; Chemical proteomics; Curcumin; Mass spectrometry; Target identification

Year:  2021        PMID: 33270200     DOI: 10.1007/978-1-0716-0954-5_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome.

Authors:  Kristi Y Lee; Cindy H Chau; Douglas K Price; William D Figg
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

2.  Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia-reperfusion.

Authors:  Dan-Dan Liu; Piao Luo; Liwei Gu; Qian Zhang; Peng Gao; Yongping Zhu; Xiao Chen; Qiuyan Guo; Junzhe Zhang; Nan Ma; Jigang Wang
Journal:  J Neuroinflammation       Date:  2021-08-09       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.